Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-097876

Chief Scientific Officer acquired 5,794 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sethuraman Natarajan · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-01 Grant or award : show line 1 in the form +5,794 162,144 D
Loading xslF345X03/tm2225276-2_4seq1.xml…